Status:
RECRUITING
Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.
Lead Sponsor:
Salome Kristensen
Conditions:
Giant Cell Arteritis
Polymyalgia Rheumatica
Eligibility:
All Genders
50-85 years
Brief Summary
The goal of this observational study is to expand the knowledge about development and aggreviation of diabetes mellitus in patients with giant cell arthritis and polymyalgia rheumatica. The main ques...
Detailed Description
The cohort study is a prospective national cohort study in patients with giant cell arthritis (GCA) and polymyalgia rheumatica (PMR). At baseline and follow-up visits at month 1, 3, 6, 12, and every y...
Eligibility Criteria
Inclusion
- Men or women aged 50 to 85 years
- Are diagnosed with GCA or PMR
- Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion)
- Speak and understand Danish
- Are able to give signed and dated informed consent
Exclusion
- None
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06011512
Start Date
August 1 2023
End Date
June 1 2026
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital
Aalborg, North Denmark, Denmark, 9000